Spots Global Cancer Trial Database for Managed Access Programs for ABL001, Asciminib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Managed Access Programs for ABL001, Asciminib
Official Title: Managed Access Programs for ABL001, Asciminib
Study ID: NCT04360005
Interventions
Asciminib
Study Description
Brief Summary: The purpose of this registration form is to list all Managed Access Programs (MAPs) related to ABL001, asciminib
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
